AstraZeneca: Think Medium-To-Long Term (NASDAQ:AZN)


If there’s one inventory I’ve had an nearly constant Purchase ranking for through the years, it’s the oncology therapy supplier AstraZeneca (OTCPK:AZNCF)(NASDAQ:AZN). For good causes. Probably the most direct of them being the predictably good returns itfirst lined itfinal replace

Financial Snapshot

Supply: AstraZeneca

Revenue by segment

Q1 2023 efficiency (Supply: AstraZeneca)

Back To Top